Abiopharma

General Announcement: CHANGES IN DIRECTORS INTEREST PURSUANT TO SECTION 219 OF THE COMPANIES ACT, 2016

General Announcement: DEALINGS OUTSIDE CLOSED PERIOD

General Announcement: CHANGES IN SUBSTANTIAL SHAREHOLDERS INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT, 2016

New SEC Form for ResMed Inc.

New Form 8-K - SANUWAVE Health, Inc. Filed: 2025-08-08 AccNo: 0001628280-25-039115 Size: 511 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 8-K - Strawberry Fields REIT, Inc. Filed: 2025-08-08 AccNo: 0001641172-25-022654 Size: 12 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 8-K - Strawberry Fields REIT, Inc. Filed: 2025-08-08 AccNo: 0001641172-25-022652 Size: 227 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 6-K - Haleon plc Filed: 2025-08-08 AccNo: 0001654954-25-009231 Size: 38 KB

New Form 6-K - SciSparc Ltd. Filed: 2025-08-08 AccNo: 0001213900-25-073278 Size: 21 KB

New Form 6-K - TRINITY BIOTECH PLC Filed: 2025-08-08 AccNo: 0001178913-25-002694 Size: 156 KB

New Form EFFECT - BIOVIE INC. Filed: 2025-08-07 AccNo: 9999999995-25-002514 Size: 1 KB

New Form EFFECT - DarioHealth Corp. Filed: 2025-08-07 AccNo: 9999999995-25-002524 Size: 1 KB

New Form EFFECT - CONDUIT PHARMACEUTICALS INC. Filed: 2025-08-07 AccNo: 9999999995-25-002523 Size: 1 KB

New Form EFFECT - Vigil Neuroscience, Inc. Filed: 2025-08-07 AccNo: 9999999995-25-002505 Size: 1 KB

New Form EFFECT - Vigil Neuroscience, Inc. Filed: 2025-08-07 AccNo: 9999999995-25-002506 Size: 1 KB